On May 28, a research activity on industrial development and win-win cooperation was launched in Jiangsheng. The inspection team led by Yang Chenglin, Deputy Secretary of the Party Leadership Group and Deputy Director of the Standing Committee of the People's Congress of Zhangye City, Gansu Province, and Deputy Director Xue Qin, conducted an in-depth study of Jiangxi Bio to better serve the industrial chain of Jiangxi Bio's subsidiary in Zhangye City.

On May 24, Zhang Binhua, Director of the Pharmaceutical Industry Division of the Jiangxi Provincial Department of Industry and Information Technology, along with his team and accompanied by the Municipal Industry and Information Technology Bureau, conducted an on-site inspection and research at Jiangsheng to study the company's industrial layout, product development, and technological innovation efforts. The company's General Manager Yao Xiaodong warmly received and accompanied the inspection team.

On May 24, a research team composed of Chen Lihua, member of the Party Leadership Group and Vice Chairwoman (concurrently serving) of the Provincial Women's Federation, and Xi Xiping, Deputy Director of the Industry Department of the Provincial Academy of Sciences, conducted a comprehensive and detailed inspection and research in Jiangsheng. They were accompanied by Guo Jingjing, full-time Deputy Secretary of the Party Working Committee of Jingkai District, focusing on the research and development of immune technology and purification technology.

On May 24, Chen Lihua, member of the Party Leadership Group and Vice Chairwoman (concurrently serving) of the Provincial Women's Federation, led a team to Jinggangshan Economic Development Zone to conduct research and development surveys on immunization technology and purification technology.

On May 9, under the arrangement of the "2024 Issue 1 Lushan Dialogue - Academician Visit to Ji'an in the Biopharmaceutical Industry" event, experts including Li Song, Academician of the Chinese Academy of Engineering and Deputy Director of the Medical and Health Division, and Chen Shilin, Academician of the Chinese Academy of Engineering and Chief Professor of Chengdu University of Traditional Chinese Medicine, visited Jiangsheng to investigate our company's biopharmaceutical technology innovation status.